INFI : Summary for Infinity Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Infinity Pharmaceuticals, Inc. (INFI)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.31+0.03 (+1.32%)
At close: 4:00PM EST
People also watch
IRWDAEGRAVEOSNTAARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.28
Open2.25
Bid2.01 x 2200
Ask0.00 x
Day's Range2.10 - 2.31
52 Week Range0.84 - 6.97
Volume436,584
Avg. Volume1,011,780
Market Cap114.88M
Beta2.57
PE Ratio (TTM)-2.45
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire12 days ago

    Infinity Announces Promotion of Jeffery Kutok, M.D., Ph.D. to Chief Scientific Officer

    CAMBRIDGE, Mass., Feb. 13, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) today announced that Jeffery Kutok, M.D., Ph.D. has been promoted to the role of chief scientific officer, effective immediately. In this role, Dr. Kutok will be responsible for overseeing biology and translational science efforts, including preclinical collaborations, to support the ongoing clinical development of IPI-549, Infinity's oral immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma).

  • PR Newswire19 days ago

    Infinity to Present at the 2017 BIO CEO & Investor Conference

    CAMBRIDGE, Mass., Feb. 6, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the 2017 BIO CEO & Investor Conference in New York City on Monday, February 13, 2017. ...

  • Accesswire23 days ago

    Faster FDA Approval Process Could Ignite These Biotech Stocks in 2017

    NEW YORK, NY / ACCESSWIRE / February 2, 2017 / The Biotech Industry has performed admirably in 2017, despite the negative attention drug makers have been receiving. The iShares NASDAQ Biotechnology Index ...